Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study to Evaluate Advantages and Disadvantages of TOXCLEAN As Add on Treatment to SOC in Patients with Clostridium Difficile-associated Diarrhea

NCT06839209 is registered in ClinicalTrials.gov with ABResearch S.r.l. as lead sponsor.

NCT NCT06839209
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06839209 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study to Evaluate Advantages and Disadvantages of TOXCLEAN As Add on Treatment to SOC in Patients with Clostridium Difficile-associated Diarrhea
Lead sponsor
ABResearch S.r.l.
Phase
Not applicable
Overall status
Recruiting
Start date
January 27, 2025
Completion date
December 31, 2025
Enrollment
18 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clostridium difficile diarrhea, clostridium; difficile, as cause of disease classified elsewhere